medimmune

November 6, 2015 | Sonya Burke

photo of man receiving vaccination

Maryland Health Department Confirms First Flu Case of the Season

The first laboratory-confirmed case of seasonal influenza in Maryland has been diagnosed in an adult in the Baltimore metropolitan area, according to a news release issued by the Maryland Department of Health and Mental Hygiene. The individual was not hospitalized. The flu strain was type A (H1N1). “The flu remains a highly contagious disease that […]

Read more

July 19, 2015 | Sonya Burke

Gaithersburg Public Hearing Set for Proposed MedImmune Parking Garage

The Gaithesburg City Council and Planning Commission will hold a joint public hearing at 7:30 p.m. on July 20th to discuss a schematic development plan (SDP) application for construction of a structured parking garage on the MedImmune/Astrazeneca campus. The proposed parking garage would include 1,386 spaces to serve future development on the company’s Gaithersburg campus. […]

Read more

July 7, 2015 | Krista Brick

MedImmune Honored as a ‘Small Business Champion’ (VIDEO)

Montgomery County Small Business Awards were announced June 24. MedImmune was named a Small Business Champion for its Supplier Diversity program, which promotes small business development and provides opportunities for qualified small and diverse businesses. Related:

Read more

June 25, 2015 | Laura Rowles

GGCC Names Huntley & Olenick to Board

The Gaithersburg-Germantown Chamber of Commerce (GGCC) is pleased to announce that Liz Huntley of MedImmune  and John Olenick of M&T Bank, have been elected to the GGCC Board of Directors. “It’s great to have people willing to volunteer their time and serve the business community. We are very happy to have Liz and John join […]

Read more

March 16, 2015 | Sonya Burke

Five Things to Know Today, March 16, in Montgomery County

Here are your five things to know today, March 16, in Montgomery County. 1. Montgomery County Executive Ike Leggett is scheduled to deliver his recommended fiscal year 2016 operating budget today. You can watch the announcement live on Montgomery Channel 21 beginning at 12:30 p.m. and follow @MyMCMedia on Twitter for updates before, during and […]

Read more

February 13, 2015 | Sonya Burke

Five Things to Know Today, Feb. 13, in Montgomery County

Happy Friday the 13th! Here are your five things to know today, Feb. 13, in Montgomery County: 1. Bundle up, it’s extremely cold outside. The National Weather Service has issued a wind chill advisory for Montgomery County until 10 a.m. today. 2. MedImmune officials are planning to build a child care center on the company’s […]

Read more

February 11, 2015 | Sonya Burke

MedImmune Alerts Community of Plans to Build Childcare Center

UPDATED MedImmune and AstraZeneca officials are planning to build a child care center adjacent to the company’s corporate campus at One MedImmune Way in Gaithersburg. In an email sent on Feb. 11, the biotech company alerted Quince Orchard Park community residents that a Schematic Development Plan (SDP) application for construction of the child care center […]

Read more

May 12, 2014 | Staff Writer

Members of Maryland Congressional Delegation Send Letter to Pfizer CEO

Six members of the Maryland Congressional delegation have written to Pfizer CEO Ian Read concerning the company’s potential acquisition of AstraZeneca, which employs over 3,000 in Maryland. The letter was led by Congressman John K. Delaney (MD-6) whose district includes the Gaithersburg headquarters of AstraZeneca subsidiary MedImmune. The letter was signed by Senator Barbara A. […]

Read more

January 8, 2014 | Staff Writer

MedImmune to Develop Cancer Therapies with Immunocore

AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into an oncology research collaboration and licensing agreement with Immunocore Limited, a privately-held, UK-based biotechnology company. Both companies will research and develop novel cancer therapies using Immunocore’s Immune Mobilising Monoclonal T-Cell Receptor Against Cancer (ImmTAC) technology. This platform of biological medicines, […]

Read more

December 11, 2013 | Staff Writer

MedImmune and Johns Hopkins Announce $6.5 Million Collaboration

MedImmune, AstraZeneca’s global biologics research and development arm, and Johns Hopkins University today (Dec. 11) announced they have entered into a five-year, $6.5 million research collaboration. This is a broad-scale, long-term industry-academic collaboration for Johns Hopkins. MedImmune and Johns Hopkins will each contribute funding, personnel and materials to address important scientific questions and exchange knowledge […]

Read more

Engage us on Facebook

Follow us on Twitter